ENKAM PHARMACEUTICALS ApS: Financial statements 2013
CVR: 25812921
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ENKAM PHARMACEUTICALS ApS (CVR 25812921) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -2,621,140 and a net result of DKK -3,665,105 compared with DKK -2,525,962 the year before. Equity in the 2013 report amounted to DKK -4,730,496.
- Gross Profit
- DKK -2,621,140
- Profit/Loss
- DKK -3,665,105
- Equity
- DKK -4,730,496
- Total Assets
- DKK 6,657,318
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -2.6 mio. | -3.7 mio. | -4.7 mio. | - |
| 2012 | - | -1.1 mio. | -2.5 mio. | -3.5 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ENKAM PHARMACEUTICALS ApS has published its annual report for 2012. Gross profit came to DKK -1,060,280, and the net result was DKK -2,525,962.
About ENKAM PHARMACEUTICALS ApS
ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company has been dissolved on 15 July 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 1 employee (2019). In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity in the 2018 report amounted to DKK -1,179,474.